BXN 13.3% 1.7¢ bioxyne limited

international footprint growth and penetration

  1. 1,410 Posts.
    lightbulb Created with Sketch. 131
    Great work and international footprint growing with rapid product penetration for Bioxyne and their subsidiary Global Treasure New Zealand (GTNZ) with dairy/health product BK18 and other current & new products established in -

    Philippines http://www.globaltreasure.com.ph/
    Malaysia http://www.bioxyne.com.my/index.html

    Vietnam http://gtnz.vn/

    1492999373_banner-1.jpg

    along with other surrounding Asian countries around Malaysia....... stay tuned for China!

    BXN are following through in a timely manner on what has been announced!

    ASX release 7 December 2017
    Bioxyne Limited (ASX:BXN) is pleased to advise that following the grant of a Direct Sales Licence in Malaysia the Company has launched 3 new products for the Asian market. The 3 new products are formulated and manufactured in the clean and environmentally green New Zealand.

    NH Chua, Managing Director, commented “in bringing these new products to market it is important to us to ensure that they have the utmost integrity and represents the best that New Zealand has to offer to Asia.

    Our distributor base has been eagerly awaiting these products and with the infrastructure now in place we look forward to gathering sales momentum as we move into 2018.” Direct sales marketing in Malaysia, where Bioxyne recently received a Direct Sales Licence, is estimated to be US$4 billion and is one of the fastest growing direct sales markets in Asia.

    The Company is also developing direct sales business in other Asian countries, including obtaining Direct Sales Licences where appropriate. These countries include Vietnam (direct sales market estimated at US$0.4 billion),Taiwan (direct sales estimated at US$3.3 billion) and Indonesia (direct sales estimated at US$1 billion). The commencement of marketing of all products in Malaysia, has also been boosted by an initial order of 16,000 cans of BK18™ for South East Asian countries outside of Malaysia.

    All Bioxyne’s products are formulated from ingredients which have shown in clinical studies to provide a range of health and beauty benefits. Bioxyne also has a good pipeline of exciting new products under development. These new products are scheduled for release in early 2018.

    ASX release 16 January 2018
    NH Chua, Managing Director, commented “the Company has over the last six months been focused on developing a product range in health and beauty consistent with the very best ingredients New Zealand and Australia have to offer.

    We have a pipeline of products in development. An exciting new product for the China market is at registration stage in Asia and is scheduled to be launched by 31 March 2018.”
    Last edited by zx65: 24/02/18
 
watchlist Created with Sketch. Add BXN (ASX) to my watchlist
(20min delay)
Last
1.7¢
Change
0.002(13.3%)
Mkt cap ! $26.60M
Open High Low Value Volume
1.6¢ 1.8¢ 1.6¢ $23.22K 1.367M

Buyers (Bids)

No. Vol. Price($)
2 588235 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 316000 2
View Market Depth
Last trade - 15.52pm 02/12/2024 (20 minute delay) ?
BXN (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.